The stock price of NLS Pharmaceutics Ltd (NASDAQ: NLSP) has surged by 4.66 when compared to previous closing price of 0.13, but the company has seen a -4.92% decline in its stock price over the last five trading sessions. benzinga.com reported 2024-07-29 that U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining around 0.4% on Monday.
Is It Worth Investing in NLS Pharmaceutics Ltd (NASDAQ: NLSP) Right Now?
The 36-month beta value for NLSP is also noteworthy at -0.53. There are mixed opinions on the stock, with 0 analysts rating it as a “buy,” 0 rating it as “overweight,” 1 rating it as “hold,” and 0 rating it as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for NLSP is 29.84M, and at present, short sellers hold a 3.98% of that float. The average trading volume of NLSP on September 12, 2024 was 11.78M shares.
NLSP’s Market Performance
The stock of NLS Pharmaceutics Ltd (NLSP) has seen a -4.92% decrease in the past week, with a -28.32% drop in the past month, and a 8.43% gain in the past quarter. The volatility ratio for the week is 8.54%, and the volatility levels for the past 30 days are at 8.37% for NLSP. The simple moving average for the past 20 days is -14.70% for NLSP’s stock, with a -51.28% simple moving average for the past 200 days.
NLSP Trading at -26.47% from the 50-Day Moving Average
After a stumble in the market that brought NLSP to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.69% of loss for the given period.
Volatility was left at 8.37%, however, over the last 30 days, the volatility rate increased by 8.54%, as shares sank -22.36% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -32.45% lower at present.
During the last 5 trading sessions, NLSP fell by -4.93%, which changed the moving average for the period of 200-days by -66.24% in comparison to the 20-day moving average, which settled at $0.1564. In addition, NLS Pharmaceutics Ltd saw -77.10% in overturn over a single year, with a tendency to cut further losses.
Stock Fundamentals for NLSP
The total capital return value is set at 1.94.
Based on NLS Pharmaceutics Ltd (NLSP), the company’s capital structure generated -0.23 points at debt to capital in total, while cash flow to debt ratio is standing at -5.93. The debt to equity ratio resting at -0.18. The interest coverage ratio of the stock is -81.34.
Currently, EBITDA for the company is -11.8 million with net debt to EBITDA at -0.06. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.23.
Conclusion
In summary, NLS Pharmaceutics Ltd (NLSP) has had a bad performance as of late. Analysts have mixed opinions on the stock, with some viewing it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
